• What role does Clinical Supply Chain plan with respect to drug accountability and reconciliation? What role does Clinical Operations Play? Who has overall responsibility? How is that achieved?
• What are some best practices on ensuring that clinical supply is meeting requirements of blinded studies? Is your CSC blinded or unblinded? Do they interact with study teams? Patient sites?